ELITE PHARMACEUTICALS INC /NV/ 4/A
4/A · ELITE PHARMACEUTICALS INC /NV/ · Filed May 13, 2015
Insider Transaction Report
Form 4/AAmended
NIGALAYE ASHOK G
DirectorChief Scientific Officer10% Owner
Transactions
- Other
Common Stock
2015-04-23+19,275,135→ 38,442,230 total
Footnotes (3)
- [F1]Disposition of common stock to its members.
- [F2]Ashok Nigalaye is an equity owner and executive officer of each of Epic Pharma, LLC ("EP"), and Epic Investments, LLC ("EI") (which is controlled by EP), which was a 10% owner of the issuer, and also serves as a director of the issuer. Reporting person received these securities pursuant to a distribution by EI to members of Epic Pharma, LLC.
- [F3]In the original filing, the number of shares acquired was under reported by two shares and there was an addition error in the total number of shares owned. This amended filing corrects both of these numbers.